<DOC>
	<DOCNO>NCT00506441</DOCNO>
	<brief_summary>This phase III multi-centre study three period : first period phosphate binder washout 4 week , second period open-label , flexible dose titration , third period placebo-controlled withdrawal compare MCI-196 placebo 4 week .</brief_summary>
	<brief_title>A Phase 3 , Randomized , Double Blind , Placebo-Controlled , Multi-Center , Withdrawal Study MCI-196 CKD Dialysis With Hyperphosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>Male female , &gt; =18 year old Stable hemodialysis peritoneal dialysis Subjects Stable phosphate control Subjects Stabilized phosphorus diet Subjects undergo regular dialysis treatment Female childbearing potential negative serum pregnancy test . Male subject must agree use appropriate contraception . Current clinically significant medical comorbidities , may substantially compromise subject safety , expose undue risk , interfere significantly study procedure , opinion Investigator , make subject unsuitable inclusion study . serum albumin level &lt; 3.0g/dL PTH level &gt; 1000pg/mL Hemoglobin level &lt; 8mg/dL A History significant gastrointestinal motility problem Biliary obstruction proven liver dysfunction A positive test hepatitis B surface antigen , hepatitis C antibody HIV 1 2 antibody A clinically significant severe lactose intolerance sensitivity A history substance alcohol abuse within last year . Seizure disorder A history drug allergy use cholestyramine , colestipol colesevelam Schedule receive kidney transplant within next 6 month Participation clinical study experimental medication last 30 day experimental biological product within last 90 day prior sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Hyperphosphatemia</keyword>
	<keyword>Phosphate binder</keyword>
</DOC>